glp 1 in obesity Direct and indirect effects of GLP1‐RA obesity, T2D and MASLD GLP-1 receptor agonism: a transformative

doi:10.1164/rccm.201511-2260OC Labarca G, Reyes T, Jorquera J, Dreyse J, Drake L

A new study has found that when it comes to the neuroprotective abilities of diabetes medications, people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users

Practical Applications of Vehicle Control within the Distributed Processing Architecture, Proceedings of the 1992 American Control Conference, Ruggirello, Joseph A., Bielawski, Dennis A., and Diaz, R

The Takeaway Insurance coverage for GLP-1 obesity medications like Wegovy and Zepbound depends on your plan and whether the medications are prescribed for weight loss or another FDA-approved health condition